Patent

The US Patent and Trademark Office and case law have created confusion around IP

Sequenom case leaves pharma confused over patent law

By Fiona BARRY

US intellectual property (IP) rules and a string of recent court cases are reducing the types of inventions pharma companies can patent, and “calling into question entire portfolios,” says a specialist lawyer.